About: Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease: A Critical Review     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • In the introductory chapter, the critical review about the use of small molecules of natural origin deals with the consequences of pathophysiological processes of Alzheimer's disease (AD) as essential basis for rational intervention to moderation of this disease. Substantial attention is given to impact on beta-amyloid (A beta) production, undesirable destructive processes, which take place in central nervous system on the basis of A beta activity, and possibilities of their affection (use of alpha-secretase elicitors, BACE1 inhibitors, antioxidants and scavengers, inhibitors of A beta-induced neurotoxicity, and A beta oligomer aggregation). Inhibitors of A beta-induced inflammation of cells and agonists of PPARgamma transcription factors also play significant role in this issue. During the AD progression, it is necessary to pay attention to tau-protein metabolism which is pathologically associated with tangles (glutaminyl cyclase inhibitors), and to interactions of A beta with the receptors for final products of advanced glycation (inhibitors of RAGEs). Within the scope of cholinergic theory, the attention is paid on natural cognitive drugs (inhibitors of acetyl- and butyrylcholinesterase), substances improving brain metabolism (nootropics), and compounds affecting brain concentration of some neuromediators (inhibitors of prolyl endopeptidase).
  • In the introductory chapter, the critical review about the use of small molecules of natural origin deals with the consequences of pathophysiological processes of Alzheimer's disease (AD) as essential basis for rational intervention to moderation of this disease. Substantial attention is given to impact on beta-amyloid (A beta) production, undesirable destructive processes, which take place in central nervous system on the basis of A beta activity, and possibilities of their affection (use of alpha-secretase elicitors, BACE1 inhibitors, antioxidants and scavengers, inhibitors of A beta-induced neurotoxicity, and A beta oligomer aggregation). Inhibitors of A beta-induced inflammation of cells and agonists of PPARgamma transcription factors also play significant role in this issue. During the AD progression, it is necessary to pay attention to tau-protein metabolism which is pathologically associated with tangles (glutaminyl cyclase inhibitors), and to interactions of A beta with the receptors for final products of advanced glycation (inhibitors of RAGEs). Within the scope of cholinergic theory, the attention is paid on natural cognitive drugs (inhibitors of acetyl- and butyrylcholinesterase), substances improving brain metabolism (nootropics), and compounds affecting brain concentration of some neuromediators (inhibitors of prolyl endopeptidase). (en)
Title
  • Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease: A Critical Review
  • Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease: A Critical Review (en)
skos:prefLabel
  • Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease: A Critical Review
  • Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease: A Critical Review (en)
skos:notation
  • RIV/00216208:11160/14:10282051!RIV15-MSM-11160___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, P(EE2.3.20.0235)
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 31713
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11160/14:10282051
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Critical review; Prospects of use; Alzheimer's disease; Natural substances; Small molecules (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...ontrolniKodProRIV
  • [3DEDA49DE802]
http://linked.open...i/riv/mistoVydani
  • Oxford/Amsterdam
http://linked.open...vEdiceCisloSvazku
  • vol. 42
http://linked.open...i/riv/nazevZdroje
  • Studies in Natural Products Chemistry
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...v/pocetStranKnihy
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...iv/tvurceVysledku
  • Cahlíková, Lucie
  • Chlebek, Jakub
  • Hošťálková, Anna
  • Macáková, Kateřina
  • Opletal, Lubomír
  • Benešová, Nina
number of pages
http://bibframe.org/vocab/doi
  • 10.1016/B978-0-444-63281-4.00006-9
http://purl.org/ne...btex#hasPublisher
  • Elsevier
https://schema.org/isbn
  • 978-0-444-63281-4
http://localhost/t...ganizacniJednotka
  • 11160
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software